Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adhesion G protein-coupled receptor L1 (ADGRL1), also known as Latrophilin-1, is a member of the adhesion G protein-coupled receptor (aGPCR) family characterized by an extended extracellular region containing multiple protein domains, including lectin and olfactomedin domains, fused to a 7-transmembrane domain typical of GPCRs via a GAIN autoproteolysis domain[2][1]. ADGRL1 plays key roles in cell adhesion, synaptic development, and signal transduction in the nervous system[1][5][2]. It serves as a high-affinity receptor for the neurotoxin alpha-latrotoxin from black widow spider venom, which can induce massive neurotransmitter release[3][4]. Physiologically, ADGRL1 regulates synapse formation, neuronal signaling, and energy and glucose balance, and interacts with several ligands including teneurins, neurexins, and FLRT proteins[1][4][2]. Mutations in ADGRL1 are linked to neurodevelopmental and neuropsychiatric disorders, including intellectual disability, autism spectrum disorder, ADHD, epilepsy, and also contribute to obesity and cancer risk[1][7][5][3]. ADGRL1 is considered a prototypical adhesive GPCR important for brain function; however, as of current knowledge, it is not directly targeted by any approved pharmacological agents.
Alpha-latrotoxin binds and activates ADGRL1, inducing massive exocytosis of neurotransmitters[3][4]. Endogenous peptide agonists activate G-protein signaling downstream[5]. General GPCR mechanism: Activation leads to intracellular G-protein signal transduction cascade[5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adhesion G protein-coupled receptor L1 (ADGRL1).